Robbie Woodman
Chairman at Transine Therapeutics Ltd.
Network origin in Robbie Woodman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Panakes Partners SGR SpA
 Panakes Partners SGR SpA Investment ManagersFinance Panakes Partners Sgr SpA (Panakes Partners) is a venture capital firm founded in 2015 by Alessio Beverina, Fabrizio Landi and Diana Sareceni. The firm is headquartered in Milan, Italy.
23
| Private Company | Investment Managers | 23 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY.
11
| Subsidiary | Biotechnology | 11 |
Transine Therapeutics Ltd.
 Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California.
4
| Subsidiary | Investment Managers | 4 |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware.
4
| Holding Company | Financial Conglomerates | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robbie Woodman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Politecnico di Milano | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member Founder Chairman | |
Endostart SRL
 Endostart SRL Medical SpecialtiesHealth Technology Endostart SRL manufactures medical devices for gastrointestinal endoscopy. It specializes in medical devices based on ferrofluid and magnetic fields to guide a colonoscope along the colon, avoiding incomplete colonoscopies. The company was founded by Alessandro Tozzi on May 1, 2018 and is headquartered in Certaldo, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
| GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Universita Degli Studi Del Sannio | College/University | Undergraduate Degree Undergraduate Degree | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SmartZyme Biopharma, Inc.
 SmartZyme Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services SmartZyme Biopharma, Inc. provides platform for protein design and engineering in accordance with industry required specifications. The company was founded by David Baram and Shilo Ben Zeev in 2013 and is headquartered in Ness Ziona, Israel. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| University of Birmingham | College/University | Undergraduate Degree Doctorate Degree | |
| ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
| The University of Alabama School of Medicine | College/University | Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| University of Milan | College/University | Doctorate Degree | |
Fidim Srl
 Fidim Srl MiscellaneousMiscellaneous Fidim Srl operates as a holding company. The company is headquartered in Monza, Italy. | Miscellaneous | Corporate Officer/Principal | |
| Vanderbilt University | College/University | Undergraduate Degree | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Rottapharm SpA
 Rottapharm SpA Pharmaceuticals: MajorHealth Technology Rottapharm SpA engages in the research, development, manufacture, and marketing of pharmaceuticals and products for wellness and personal care. Its products are distributed through the following categories: Semi-ethical, which includes prescribed and non-reimbursed, non-reimbursed, and over-the-counter medicines, cosmetics, nutraceuticals, and medical equipment; Reimbursed pharmaceuticals; and Natural extracts, which carry the brand Euromed. The company was founded by Luigi Rovati in 1961 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Olatec Therapeutics LLC
 Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
| ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Director/Board Member | |
| Universita Cattolica Del Sacro Cuore | College/University | Undergraduate Degree | |
SIFI SpA
 SIFI SpA Pharmaceuticals: MajorHealth Technology SIFI SpA develops and manufactures pharmaceutical specialties, nutraceuticals and ophthalmic cosmetics. It is a ophthalmic company to feature an full-cycle, integrated business model, including research, development, manufacturing and marketing of pharmaceutical specialties and surgical and medical devices. The company was founded in 1935 and is headquartered in Lavinaio, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
| Weizmann Institute of Science | College/University | Doctorate Degree | |
| Xanadu Bio Inc. | Founder | ||
| ASP ISOTOPES INC. | Pharmaceuticals: Major | Director/Board Member | |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Biotechnology | Director/Board Member | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Director/Board Member | |
Assobiotec
 Assobiotec Miscellaneous Commercial ServicesCommercial Services Assobiotec is an organization that represents approximately 130 companies and technological and scientific parks in the biotech sector. Assobiotec is based in Milan, Italy. The Italian company focuses on various areas such as health, agriculture, environment, and industrial processes. The private company was founded in 1986, and the CEO is Leonardo Vingiani. | Miscellaneous Commercial Services | Director/Board Member | |
| Wider Film Projects | Corporate Officer/Principal | ||
| Princeton University | College/University | Undergraduate Degree | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
BioRep S.r.l
 BioRep S.r.l Miscellaneous Commercial ServicesCommercial Services BioRep S.r.l is a private company based in Milan, Italy. BioRep is a centro di risorse biologiche, which translates to a biological resources center. The Italian company was founded in 2003. Gervasoni Vincenzo has been the CEO of the company since 2010. | Miscellaneous Commercial Services | Chairman | |
Rottapharm Biotech SRL
 Rottapharm Biotech SRL BiotechnologyHealth Technology Rottapharm Biotech SRL operates as a drug research and development company. The company was founded in 1961 and is headquartered in Monza, Italy. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 35 |
| Italy | 13 |
| Israel | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operational
| Director/Board Member | 218 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 42 |
| Private Equity Investor | 31 |
| Chief Executive Officer | 22 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Stephen P. Squinto | 40 |
| Erez Chimovits | 30 |
| Fabrizio Landi | 19 |
| Todd Wider | 15 |
| Alessio Beverina | 12 |
| Victor Stone | 12 |
| Jayson Punwani | 12 |
| Alan Keith Boyd | 12 |
| Diana Saraceni | 11 |
| Alvin Shih | 11 |
| Francesco Ceci | 10 |
| Hikaru Saito | 10 |
| Marco Sardina | 10 |
| Sacha Mann | 9 |
- Stock Market
- Insiders
- Robbie Woodman
- Company connections
